PRE PRENETICS GLOBAL LIMITED

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14 to February 16, 2023.

About Prenetics

Founded in 2014, Prenetics is a major global diagnostic and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Consumer Health, Clinical Care and Medical & Cancer Genomics — comprehensive and accessible to anyone, at anytime and anywhere. Prenetics is led by visionary entrepreneur, Danny Yeung, with operations across nine locations, including The United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening and provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing. Prenetics is listed on NASDAQ with the ticker PRE. To learn more about Prenetics, visit .

Investor Relations Contact:
 
ICR Westwicke:
Caroline Corner Email:
   
Media contact:
Strategic Public Relations Group
Corinne Ho  Email:





EN
02/02/2023

Underlying

PREPRENETICS GLOBAL LIMITED

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as...

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE)In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recurring RevenueIM8 has built a loyal customer base of 60,000+ users who have consumed over 5 million servingsIM8, co-founded by David Beckham is available at CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a le...

June 26, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitco...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board -  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLO...

June 18, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to U...

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 millionPrenetics simplifies investment thesis as company focuses on high-growth consumer health brands IM8, CircleDNA, and EuropaPrenetics raised its FY2025 outlook to be US$80 – US$100 million from $73 – US$85 million, driven by the growth of IM8 CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a ...

June 18, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Announces First Quarter 2025 Financial Results, Raises FY202...

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100 million (excluding ACT Genomics)IM8 contributed $5.7 million in Q1, with $2.8 million in March alone & provides Q2 revenue projectionsIM8 has more than 55,000 customers with 4.9 million servings delivered and countingDetails of crypto strategy and Bitcoin adoption to be announced soon as part of innovative treasury approach CHARLOTTE, N.C., Ju...

June 12, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studde...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- On Monday, , the premium supplement brand co-founded by , hosted IM8 Vibrante - A Celebration of Science, Wellness & Flavor, a memorable evening at the iconic on Miami Beach. In attendance were nearly 150 wellness influencers, creators, science and medical advisors, and media members to celebrate...

April 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch